Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Just went on their new website www.sunshinebiopharma.com click publications and you will see preclinical results at the end of results you will see references. So many scientists from all around the world here. OMG never noticed this before. This is serious work here. It's over 25 years of studies here
We Love you Sunshine Biopharma. Keep up the great work!!!
Special Thanks To Dr.Slilaty for your hard work and determination And never giving up the fight.You Deserve The Nobel . We Love you
We love You Sunshine Biopharma :)
How Much Do You Think Sunshine Biopharma Buyout would be After phase1 clinical trials
We Love you Dr. Slilaty Thank you for your hard work and dedication
You are my Sunshine My only Sunshine!!! I love you
Can you imagine what will happen over here
This is the first of its kind in the world
ADVA-27a The one and only Hope for cancer patience
Sunshine Biopharma making history with ADVA-27a
Hit the ask before its too late!!!
ADVA27A New Hope For Cancer Patients on the way
ADVA-27a The Most advanced technology in the world!!!
Congratulations Dr.Slilaty your going to do it Your a Pioneer
Adva-27a major Scientific Breakthrough
Adva-27a major Scientific Breakthrough
The sunshine is heating up for major Impact in the clinic
One of a kind opportunity comes only once in a lifetime... never forget that :)
Shareholders applaud "One of a kind Breakthrough Technology ADVA-27A"
Adva-27a Carbon-Difluoride Breakthrough Technology New hope for breast cancer patients.
Many therapeutically important compounds contain diester bonds that link different parts of the molecule together. Diester bonds are naturally unstable often leading to suboptimal performance when the molecule is administered to patients. Diester bonds have specific electrostatic properties and three-dimensional structure that cannot be easily mimicked by other bonds. Chemical structures that do not mimic the diester bond correctly invariably render the compound biologically inactive. In collaboration with Institut National des Sciences Appliquées de Rouen in France (“INSA”), our licensor, Advanomics Corporation, has developed a way to replace the diester bond with a Carbon-Difluoride bond which acts as a perfect diester isostere. An isostere is a different chemical structure that mimics the properties of the original. In the body, Carbon-Difluoride compounds are resistant to metabolic degradation but are recognized similarly to the diester containing compounds (see Figure below). This technology allows us to create a large variety of therapeutic compounds that are completely stable and often more active than the original drugs.
This unique capability allowed us to create our Lead Compound, Adva-27a, an effective and highly specific Topoisomerase II (Top2) Inhibitor. Our in vitro studies have shown that Adva-27a is very effective at killing a variety of cancer types including Multi-Drug Resistant Breast Cancer.
In regards to Doctor Slilaty and Management spectacular job. Lets hope adva27-a will reach to its highest potential.
Couldn't resist knowing that there is hope for breast cancer patients! HOPE is all we need and have for this incurable disease!!!!!!
any new drug for breast cancer thats non toxic?